Roh JL - Search Results

1

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.

Lee J, You JH, Kim MS, Roh JL. Lee J, et al. Among authors: roh jl. Redox Biol. 2020 Oct;37:101697. doi: 10.1016/j.redox.2020.101697. Epub 2020 Aug 28. Redox Biol. 2020. PMID: 32896720 Free PMC article.

2

Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.

Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH. Lee DW, et al. Among authors: roh jl. Anticancer Res. 2002 Jul-Aug;22(4):2089-96. Anticancer Res. 2002. PMID: 12174888

3

Activation of p53-p21 is closely associated with the acquisition of resistance to apoptosis caused by β1-integrin silencing in head and neck cancer cells.

Kim MR, Chang HW, Nam HY, Han MW, Moon SY, Kim HJ, Lee HJ, Roh JL, Kim SW, Kim SY. Kim MR, et al. Among authors: roh jl. Biochem Biophys Res Commun. 2012 Feb 10;418(2):260-6. doi: 10.1016/j.bbrc.2012.01.007. Epub 2012 Jan 11. Biochem Biophys Res Commun. 2012. PMID: 22266309

4

The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.

Roh JL, Ko JH, Moon SJ, Ryu CH, Choi JY, Koch WM. Roh JL, et al. Cancer Lett. 2012 Dec 1;325(1):35-41. doi: 10.1016/j.canlet.2012.05.020. Epub 2012 May 22. Cancer Lett. 2012. PMID: 22634494

5

Epithelial-mesenchymal transition: clinical implications for nodal metastasis and prognosis of tongue cancer.

Han MW, Lee JC, Kim YM, Cha HJ, Roh JL, Choi SH, Nam SY, Cho KJ, Kim SW, Kim SY. Han MW, et al. Among authors: roh jl. Otolaryngol Head Neck Surg. 2015 Jan;152(1):80-6. doi: 10.1177/0194599814556061. Epub 2014 Nov 11. Otolaryngol Head Neck Surg. 2015. PMID: 25389317

6

Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.

Roh JL, Kim EH, Park JY, Kim JW. Roh JL, et al. Mol Cancer Ther. 2015 Aug;14(8):1907-15. doi: 10.1158/1535-7163.MCT-15-0171. Epub 2015 Jun 10. Mol Cancer Ther. 2015. PMID: 26063766

7

Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.

Roh JL, Park JY, Kim EH, Jang HJ, Kwon M. Roh JL, et al. Cancer Lett. 2016 Feb 1;371(1):20-9. doi: 10.1016/j.canlet.2015.11.023. Epub 2015 Nov 23. Cancer Lett. 2016. PMID: 26607904

8

Targeting acid ceramidase sensitises head and neck cancer to cisplatin.

Roh JL, Park JY, Kim EH, Jang HJ. Roh JL, et al. Eur J Cancer. 2016 Jan;52:163-72. doi: 10.1016/j.ejca.2015.10.056. Epub 2015 Dec 11. Eur J Cancer. 2016. PMID: 26687835

9

Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.

Roh JL, Kim EH, Jang HJ, Park JY, Shin D. Roh JL, et al. Cancer Lett. 2016 Oct 10;381(1):96-103. doi: 10.1016/j.canlet.2016.07.035. Epub 2016 Jul 28. Cancer Lett. 2016. PMID: 27477897

10

Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.

Kim EH, Jang H, Shin D, Baek SH, Roh JL. Kim EH, et al. Among authors: roh jl. Apoptosis. 2016 Nov;21(11):1265-1278. doi: 10.1007/s10495-016-1284-8. Apoptosis. 2016. PMID: 27544755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters